- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Florida Cancer Specialists, Cigna Expand Collaboration to All Cancer Types
A 28% reduction in hospital admissions leads to a broader agreement, the physicians' group and payer say.
Florida Cancer Specialists and Research Initiative (FCS) and the insurer Cigna are expanding their collaboration for value-based cancer care. Since 2015, FCS has provided services to Cigna patients through a collaborative care arrangement that included extra support, education, and efforts to reduce hospitalization and unnecessary visits to the emergency department.
Those efforts were initially offered to patients with breast, lung, and colorectal cancers, leukemia, and lymphoma and resulted in a 28% lower inpatient admission rate compared with patients outside the value-based model. So now, the collaboration will involve patients with all cancer diagnoses and provide additional treatment therapies.
For more, see the full press release here.
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More
